Sujanu Combination Tablets, manufactured by MSD, contain Sitagliptin phosphate hydrate, Ipragliflozin, and L-proline, YJ code 3969107F1022, 1 tablet. This combination medication is typically indicated for the management of type 2 diabetes.
Sujanu Combination Tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).